Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation

Oliver Grottke, John W. Eikelboom(Population Health Research Institute), Alex C. Spyropoulos(Lenox Hill Hospital), Menno V. Huisman(Leiden University Medical Center), Thorsten Steiner(Heidelberg University), Jerrold H. Levy(Duke University), Richard A. Bernstein(Northwestern University), Charles V. Pollack(Hospital of the University of Pennsylvania), Dara G. Jamieson(Cornell University), Patrick Goldstein(Centre Hospitalier Universitaire de Lille), Gregory J. del Zoppo(University of Washington), James Aisenberg(Icahn School of Medicine at Mount Sinai)
Critical Care
April 28, 2016
10.1186/s13054-016-1275-8
Cited by 47

Related Papers

Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
|European Heart Journal|2014|3.1k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
|New England Journal of Medicine|2017|2.4k